Delivery Order SPE2DB24D2212-SPE2DB25FHPRH
- Not listed
- The Defense Logistics Agency awarded a $1,941.36 delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count package) on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price, competitively awarded contract (non-set-aside) will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,941.36 for INBRIJA 42 mg inhalation capsules (60-count) by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price, competitively awarded procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,251.00 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564542915 INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of May 30, 2024. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to...
- This is a $1,294.24 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug INBRIJA 42 MG INHALATION CAP 60S, with a performance period through March 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a...
- The Defense Logistics Agency awarded a $2,502 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,694,800 INBRIJA 42 MG INHALATION CAP 60S. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 60 units of the medication INBRIJA 42 MG INHALATION CAP. The contract has a ceiling value of $1,941.36 and a performance period ending on July 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order for $1,251.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 60 units of INBRIJA 42 MG INHALATION CAP pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the prime contract vehicle for the company to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INBRIJA 42 MG INHALATION CAP 60S. The contract has a ceiling value of $1,294.24 and runs through April 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 60 units of the medication INBRIJA 42 MG INHALATION CAP. The contract has a ceiling value of $1,294.24 and a performance period through July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product. The award has a total ceiling value of $7,506.00 and a period of performance through May 3, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHPRHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of INBRIJA 42 mg inhalation capsules (60-count units) with a ceiling value of $1,941.36. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by May 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor supporting federal medical procurement. This delivery order represents a child contract issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion vehicle running through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide. Through this contract structure, the company serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities, with INBRIJA representing a specialty pharmaceutical product within the company's broad portfolio of federal medical supply deliveries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 5/2/25 |